Continuous Subacromial Bupivacaine
Information source: Turku University Hospital
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Shoulder Arthroscopy
Intervention: bupivacaine (Drug)
Phase: N/A
Status: Completed
Sponsored by: Turku University Hospital
Summary
The investigators wanted to re-evaluate the effects of subacromial bupivacaine infusion
after shoulder arthroscopy with standard surgical techniques, including rotator cuff
operations. The investigators hypothesized that patients having 5. 0 mg/ml bupivacaine
infusion at a rate of 2 ml/h subacromially would need less opioids than patients receiving a
placebo infusion.
Clinical Details
Official title: The Analgesic Effect of Continuous Subacromial Bupivacaine Infusion After Arthroscopic Shoulder Surgery: a Randomized Controlled Trial
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Primary outcome: The consumption of analgesics (oxycodone)
Secondary outcome: The intensity of pain
Detailed description:
Shoulder surgery has become a routine outpatient procedure. Previously shoulder surgery was
associated with intense, occasionally severe postoperative pain and hence considerable use
of opioids. Also arthroscopic shoulder surgery, especially rotator cuff procedures, may
cause significant pain resulting sometimes in inpatient admission. Subacromial local
anaesthetic infusion as a part of a multimodal approach is one commonly used modality to
pain relief after shoulder surgery. Nevertheless, it has been criticized recently for its
poor benefits and possible adverse effects. On the whole, the scientific evidence of the
advantages of local anaesthetic infusions is inconclusive.
Eligibility
Minimum age: 20 Years.
Maximum age: 70 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- subacromial impingement disease
- scheduled for an elective arthroscopic surgery
Exclusion Criteria:
- liver disease
- renal impairment
- psychiatric disorder
- alcohol abuse
- obesity (a body mass index of > 35 kg/m2)
- allergies to the drugs used in the study
Locations and Contacts
Turku University Hospital and University of Turku, Turku, Finland
Additional Information
Starting date: January 2009
Last updated: June 21, 2011
|
